India’s first COVID-19 Vaccine – “Covaxin” prospect accepted for human tests

Bharat Biotech, based in Hyderabad has created a potential vaccine to fight the Covid-19 disease. This vaccine is called Covaxin and portrays India’s attempt in restraining the spread of Coronavirus that has ruined numerous countries throughout the world.

 

Bharat Biotech’s Covaxin comprises a weakened version of the SARS-CoV-2 virus which will be injected into the sufferer’s body to evoke an immune response. India’s COVID-19 vaccine has been created with joint efforts of Bharat Biotech, Indian Council of Medical Research (ICMR), and National Institute of Virology (NIV).

 

Approval to carry out human trials was provided by the Controller General of India as a report on the potency of the vaccine was presented. The company now has the power to perform Phase I and II clinical trials of Covaxin, which will start in July 2020.

 

The information of a potential domestic vaccine dropped at a time when India is having a hard time to contain the spread of the virus in its significant cities. On June 29, 2020, India reported an enormous rise of 18,000 new Coronavirus infections. As of now, about 5.6 lakh people in India have been affected and the country’s death toll count is 16,800.  

 

In the list of highly affected cities, India’s financial capital hub Mumbai, Delhi, and state of Tamil Nadu are present. About 1.60 lakh people in Maharashtra have contracted this disease because of which Maharashtra’s state government is planning to extend the lockdown up to 31 July, 2020.

 

With an unprecedented rise in infections per day, India needs a tight grip, in the form of a possible cure or drug, over the Coronavirus endanger to retrieve. 

 

The easily available steroid drug Dexamethasone has lately shown the capability to decrease COVID-19 fatalities by one-third and one-fifth in severely ill patients. Dexamethasone is a prescription drug that is easily available throughout all drug shops in the country. 

 

One more drug, Remedesivir, can enhance the recovery time of sufferers leading to a speedy recovery. These drugs when combined with the approaching vaccine can be beneficial in decelerating the spread of this infectious disease.

Leave a Reply

Your email address will not be published. Required fields are marked *